Center investigators recently participated in the Invest in ME Research 2026 conference week at the Wellcome Genome Campus in Cambridge, UK, attending both the 15th Biomedical Research into ME Colloquium (BRMEC15) and the 18th International ME Conference. This annual gathering represents one of the most significant forums for ME/CFS research collaboration, bringing together international researchers, clinicians, and patient advocates to advance understanding of myalgic encephalomyelitis. Our Center’s continued participation reflects our commitment to fostering global partnerships and contributing to the growing body of biomedical research addressing this complex disease.

We’re particularly proud that one of our early career investigators, Dr. Erin Wissink, received 1st place for the Outstanding Oral Presentation Award from Young EMERG for her talk entitled “Cytotoxic T cell dysregulation in ME/CFS.” The presentation outlined a hypothesis that metabolic differences in T cells in ME/CFS cause changes in mTOR signaling and mRNA translation, based on findings from our recent single-cell genomics dataset. This recognition highlights the innovative research emerging from our Center and the importance of supporting early career scientists in ME/CFS research, particularly as the field continues to expand with growing recognition of post-viral illness connections.